Clinical Research Of Greater Trochanter Of Femur Bone Vane Binding With Bone Marrow Stem Cell To Treat ONFH

Objective: to approach clinic therapeutic effect of Greater trochanter of femur bone vane binding with bone marrow stem cell to treat ONFH, follow up and to summarize the clinic curative effect for treat ONFH especially those in the morning and early metaphase (FicatⅡ-Ⅲ). to supply theary and practice basement who endertake the clinical operation.Methods:retrospective analysis 22pou(34hip) patient from September,2008 to November,2010 who have carried out the therapy of Greater trochanter of femur bone vane binding with bone marrow stem cell, which obtained clinic followed-up visit at the same time consistent with international Staging standardization (ARCO or Ficat) and typing; make use of Harris hip Joint function scoring system and the change of perioperatively Ficat Staging, then give imageology evaluation.to command the pou 22 patient devided into 2 random group (ie the healing group and the control group), the healirg group and the control group both have receiving expectant treatment. All have pain in articulatio coxae and articular genu, limping 18 instance, and articulatio coxae functional disturbance 13 instance. Through statistic analysis, both group have eqilibrite in age of onset, Ficat staging, pathogeny and the process staging, clearly posseee comparability.Result:follow up about 3-24 month (average of 16.2 month), the pain condition ease for 9 instance (82per cenr t); Joint function improved for 7 instance (64percenrt), walking time lasting for 7 instance(73percenrt). And the satisfaction rate of the aftereffect i s 77.8%. the articulatio coxae survival rate among 73.0%～92.2%, among which traumatic occlusion and the ideo-patient improved well, hormone and alc0hol patients coparatively bad. To contrast the healing group and the control group, the fineness rate and the total effective rate pocess significant difference.Conclusion: the administration of t he Greater trochanter of femur bone vane binding with bone marrow stem cell to treat ONFH certainty possess reliability, and the patient compliance are well, comparatively better than the control group, is a sort of therapy comparatively effective in treat ONFH, especially which Staging in FicatⅡ-Ⅲ.